Research Project

Project Title:	A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Pediatric kidney transplantation
Project Summary:	The purpose of this study is to evaluate the reactogenicity, safety and immunogenicity of 2 doses of PED-HZ/su, GSK's vaccine candidate for the prevention of Herpes Zoster (HZ) in immunocompromised paediatric renal transplant recipients aged 1-17 years
Lead principal investigator(s):	Giovanni Montini, Milan
Co-investigator(s):	Sara Testa, Milan Gema Ariceta, Barcelona
Project Period:	10/2019 - 02/2025
Sponsors:	Industry
ClinicalTrials.gov:	NCT04006808
EudraCT Nr.:	2019-000607-33